Low-level mosaicism for trisomy 16 at amniocentesis in a pregnancy associated with intrauterine growth restriction and a favorable outcome.


Journal

Taiwanese journal of obstetrics & gynecology
ISSN: 1875-6263
Titre abrégé: Taiwan J Obstet Gynecol
Pays: China (Republic : 1949- )
ID NLM: 101213819

Informations de publication

Date de publication:
Mar 2021
Historique:
accepted: 14 12 2020
entrez: 8 3 2021
pubmed: 9 3 2021
medline: 22 9 2021
Statut: ppublish

Résumé

We present low-level mosaicism for trisomy 16 at amniocentesis in a pregnancy associated with intrauterine growth restriction (IUGR) and a favorable outcome. A 31-year-old woman underwent amniocentesis at 24 weeks of gestation because of IUGR. Amniocentesis revealed a karyotype of 47,XX,+16 [3]/46,XX [22]. Simultaneous array comparative genomic hybridization (aCGH) analysis on the DNA extracted from uncultured amniocytes revealed gene dosage increase in chromosome 16 consistent with 28% mosaicism for trisomy 16. Uniparental disomy (UPD) 7 and UPD 11 were excluded. She underwent repeat amniocentesis at 27 weeks of gestation. Repeat amniocentesis revealed a karyotype of 47,XX,+16 [1]/46,XX [24]. Simultaneous aCGH analysis on the DNA extracted from uncultured amniocytes revealed 25%-35% (log Cytogenetic discrepancy between cultured amniocytes and uncultured amniocytes may present in mosaic trisomy 16 at amniocentesis. Low-level mosaicism for trisomy 16 at amniocentesis without maternal UPD 16 can be associated with a favorable outcome despite the presence of IUGR.

Identifiants

pubmed: 33678340
pii: S1028-4559(21)00014-0
doi: 10.1016/j.tjog.2021.01.014
pii:
doi:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

345-349

Informations de copyright

Copyright © 2021. Published by Elsevier B.V.

Auteurs

Chih-Ping Chen (CP)

Department of Obstetrics and Gynecology, MacKay Memorial Hospital, Taipei, Taiwan; Department of Medical Research, MacKay Memorial Hospital, Taipei, Taiwan; School of Chinese Medicine, College of Chinese Medicine, China Medical University, Taichung, Taiwan; Institute of Clinical and Community Health Nursing, National Yang-Ming University, Taipei, Taiwan; Department of Obstetrics and Gynecology, School of Medicine, National Yang-Ming University, Taipei, Taiwan; Department of Medical Laboratory Science and Biotechnology, Asia University, Taichung, Taiwan. Electronic address: cpc_mmh@yahoo.com.

Ming Chen (M)

Department of Genomic Medicine, Department of Genomic Science and Technology, Changhua Christian Hospital Healthcare System, Changhua, Taiwan; Department of Obstetrics and Gynecology, Changhua Christian Hospital, Changhua, Taiwan; Department of Medical Science, National Tsing Hua University, Hsinchu, Taiwan; Department of Biomedical Science, Dayeh University, Changhua, Taiwan.

Liang-Kai Wang (LK)

Department of Obstetrics and Gynecology, MacKay Memorial Hospital, Taipei, Taiwan.

Schu-Rern Chern (SR)

Department of Medical Research, MacKay Memorial Hospital, Taipei, Taiwan.

Peih-Shan Wu (PS)

Gene Biodesign Co. Ltd, Taipei, Taiwan.

Gwo-Chin Ma (GC)

Department of Genomic Medicine, Department of Genomic Science and Technology, Changhua Christian Hospital Healthcare System, Changhua, Taiwan; Department of Biomedical Engineering, Chung Yuan Christian University, Taoyuan, Taiwan; Department of Medical Laboratory Science and Biotechnology, Central Taiwan University of Science and Technology, Taichung, Taiwan.

Shun-Ping Chang (SP)

Department of Genomic Medicine, Department of Genomic Science and Technology, Changhua Christian Hospital Healthcare System, Changhua, Taiwan.

Shin-Wen Chen (SW)

Department of Obstetrics and Gynecology, MacKay Memorial Hospital, Taipei, Taiwan.

Fang-Tzu Wu (FT)

Department of Obstetrics and Gynecology, MacKay Memorial Hospital, Taipei, Taiwan.

Chen-Chi Lee (CC)

Department of Obstetrics and Gynecology, MacKay Memorial Hospital, Taipei, Taiwan.

Yun-Yi Chen (YY)

Department of Medical Research, MacKay Memorial Hospital, Taipei, Taiwan.

Wayseen Wang (W)

Department of Medical Research, MacKay Memorial Hospital, Taipei, Taiwan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH